Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
19.53
-0.01 (-0.05%)
At close: Nov 2, 2026, 4:00 PM EST
19.53
0.00 (0.00%)
After-hours: Nov 2, 2026, 4:29 PM EST
Odyssey Therapeutics Employees
Odyssey Therapeutics had 100 employees as of June 30, 2026. That makes Odyssey Therapeutics the 31,519th largest employer in the world and 4,045th in the United States.
Employees
100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$990
Profits / Employee
-$1,600,270
Market Cap
935.85M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 100 | - | - |
| Mar 31, 2026 | 100 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 704 |
| MeiraGTx Holdings | 393 |
| Kura Oncology | 260 |
| Rigel Pharmaceuticals | 174 |
| Monte Rosa Therapeutics | 173 |
| ORIC Pharmaceuticals | 111 |
| Cullinan Therapeutics | 109 |
| Alto Neuroscience | 68 |
ODTX News
- 13 days ago - Odyssey Therapeutics Transcript: Investor update - Transcripts
- 13 days ago - Odyssey Therapeutics Press release: Investor update - Filings
- 13 days ago - Odyssey Therapeutics Slides: Investor update - Filings
- 13 days ago - Odyssey Therapeutics reports OD-001 trial meets primary endpoint - TheFly
- 13 days ago - Odyssey Therapeutics Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026 - GlobeNewsWire
- 21 days ago - Odyssey Therapeutics initiated with a Buy at UBS - TheFly
- 25 days ago - Odyssey Therapeutics initiated with an Outperform at Raymond James - TheFly
- 27 days ago - Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026 - GlobeNewsWire